



Markets
/
Stocks
/
nasdaq-gild
/

Gilead Sciences Inc

GILD

View Detailed Chart

103.170USD

-2.980-2.81%

Close 04/25, 16:00（ET）Quotes delayed by 15 min

128.55BMarket Cap

267.81P/E TTM



Gilead Sciences Inc

103.170

-2.980-2.81%

Company

Intraday

30m

Today

-2.81%

5 Days

-1.31%

1 Month

-5.58%

6 Months

+15.92%

Year to Date

+11.69%

1 Year

+57.70%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 30 analysts

BUY

Current Rating

113.480

Target Price

9.99%

Rising Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

160

Total

Median

Average

Company name

Ratings

Analysts

Gilead Sciences Inc

GILD

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

BioMarin Pharmaceutical Inc

BMRN

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(5)

Neutral(4)

Buy(3)

Indicators

Sell(1)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.057

Neutral

RSI(14)

48.085

Neutral

STOCH(KDJ)(9,3,3)

81.733

Neutral

ATR(14)

4.294

Low Volatility

CCI(14)

77.623

Neutral

Williams %R

43.215

Buy

TRIX(12,20)

-0.220

Sell

StochRSI(14)

89.358

Overbought

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

105.382

Sell

MA10

104.900

Sell

MA20

107.038

Sell

MA50

109.264

Sell

MA100

101.244

Buy

MA200

91.525

Buy

News

More news coming soon, stay tuned...

Company

Gilead Sciences, Inc. is a biopharmaceutical company. The Company is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, COVID-19, cancer and inflammation. It is focused on discovering, developing and delivering medicines to address unmet medical needs in virology, oncology and other therapeutic areas. Its portfolio of marketed products includes Biktarvy, Genvoya, Descovy, Complera/Eviplera, Symtuza, Truvada, Stribild, Sunlenca, Epclusa, Vemlidy, Harvoni, Viread, Livdelzi, Veklury, Yescarta, Tecartus, Trodelvy, AmBisome, and Letairis. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Anitocabtagene autoleucel, Sacituzumab govitecan-hziy, and Domvanalimab and zimberelimab. Biktarvy is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients. It operates in more than 35 countries worldwide.

Company codeGILD

CompanyGilead Sciences Inc

CEOMr. Daniel P. O'Day

Websitehttps://www.gilead.com/